Ven Bio Global Strategic Fund, L.P. Metacrine, Inc. (MTCR) insider trading activity
Ven Bio Global Strategic Fund, L.P. is > 10% Shareholder of Metacrine, Inc.. Currently has a direct ownership of 2.44 Million shares of MTCR, which is worth approximately $0. The most recent transaction as insider was on Oct 25, 2021, when has been sold 540,667 shares (Common Stock) at a price of $1.49 per share, resulting in proceeds of $805,594. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2.44M
0%
3M change
0%
12M change
Total Value Held
$0
venBio Global Strategic Fund, L.P. Transaction History
vGS
Ven Bio Global Strategic Fund, L.P.
> 10% Shareholder
San Francisco, CA